It was reported that tadalafil treatment improved placental mammalian/mechanistic target of rapamycin (mTOR) signaling in mouse model with L-NG-nitroarginine methyl ester (L-NAME)-induced fetal growth restriction (FGR) and associated preeclampsia (PE). The gene discussed is MTOR; the disease is fetal growth restriction.